This fusion usually encodes a BCR-ABL1 protein of 210 ​kDa (BCR-ABL1p210), which serves as a “fingerprint” that differentiates CML from other types of leukemia [3]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.